Mackay Shields LLC Bluebird Bio, Inc. Transaction History

Mackay Shields LLC

  • $499 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$88.86 - $117.49 $1.26 Million - $1.66 Million
-14,155 Closed
0 $0
Q2 2018

Aug 06, 2018
SELL
$99.64 - $127.59 $49,820 - $63,795
-500 Reduced 3.41%
14,155 $2.22 Million
Q1 2018

May 03, 2018
BUY
$105.8 - $150.94 $1.55 Million - $2.21 Million
14,655 New
14,655 $2.5 Million

Others Institutions Holding BLUE

# of Institutions
18
Shares Held
20.2M
Call Options Held
0
Put Options Held
2K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $315M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Mackay Shields LLC Portfolio

Follow Mackay Shields LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email